Ocean Biomedical Faces Delisting Concerns, Officer Changes
Ticker: OCEA · Form: 8-K · Filed: Aug 5, 2025 · CIK: 1869974
Sentiment: bearish
Topics: delisting, governance, officer-change
Related Tickers: OCEAN
TL;DR
OCEAN might be delisted, directors/officers are out, new ones in, and pay details released.
AI Summary
Ocean Biomedical, Inc. filed an 8-K on August 5, 2025, reporting events as of July 31, 2025. The filing indicates a potential delisting or failure to meet listing standards, a departure of directors or officers, and the appointment of new officers. It also mentions compensatory arrangements for certain officers and other events.
Why It Matters
This filing signals potential financial distress or governance issues at Ocean Biomedical, which could impact its stock price and investor confidence.
Risk Assessment
Risk Level: high — The filing explicitly mentions 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard,' indicating significant risk.
Key Players & Entities
- Ocean Biomedical, Inc. (company) — Filer of the 8-K report
- 0001869974 (company) — Central Index Key for Ocean Biomedical, Inc.
- 2834 (company) — Standard Industrial Classification for Pharmaceutical Preparations
- 03 Life Sciences (company) — Organization Name
- DE (company) — State of Incorporation
- 1231 (company) — Fiscal Year End
- 001-40793 (company) — SEC File Number
- 251185702 (company) — Film Number
- 515 MADISON AVE SUITE 8078 (company) — Business and Mail Address Street 1
- NEW YORK (company) — Business and Mail Address City
FAQ
What specific listing rule or standard has Ocean Biomedical, Inc. failed to satisfy, leading to the notice of delisting?
The filing does not specify the exact listing rule or standard that Ocean Biomedical, Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
Who are the directors or officers that have departed from Ocean Biomedical, Inc. as of July 31, 2025?
The filing indicates the departure of directors or certain officers but does not name the specific individuals who departed as of July 31, 2025.
Who has been elected as a director or appointed as an officer at Ocean Biomedical, Inc.?
The filing mentions the election of directors and appointment of certain officers, but the specific names of these individuals are not provided in the provided text.
What are the details of the compensatory arrangements for certain officers at Ocean Biomedical, Inc.?
The filing notes that there are compensatory arrangements for certain officers, but the specific details of these arrangements are not included in the provided text.
What other events are being reported by Ocean Biomedical, Inc. in this 8-K filing?
Besides the delisting notice, director/officer changes, and compensatory arrangements, the filing also broadly covers 'Other Events' without specifying them in the provided text.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 5, 2025 regarding Ocean Biomedical, Inc. (OCEA).